Industrywide studies report: a walk-through survey of Griffiths Laboratories USA Inc., Union, New Jersey, and Microbiotrol Inc., Bound Brook, New Jersey.
Authors
Stayner L; Morawetz JS
Source
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, IWS 67-34, YYYY MMM; :1-39
Link
NIOSHTIC No.
00154845
Abstract
A walk through survey of Griffiths Laboratories USA, Incorporated (SIC-2099), Union, New Jersey, and Microbiotrol Incorporated, Bound Brook, New Jersey, was conducted in September, 1984. The purpose of the survey was to determine the feasibility of including the facilities in a NIOSH industrywide mortality/industrial hygiene study of ethylene-oxide (75218). Ethylene-oxide, propylene-oxide (75569), or a 12 to 88 percent ethylene-oxide/freon mixture were used for sterilization. Ethylene-oxide exposures were fairly well controlled at the Union facility; however, significant exposures still existed for the retort and grinder operators. Data for the Bound Brook facility was limited, but indicated that isolating the treatment and aeration operations reduced exposures. Significant exposures still occurred, however, for the process operators and assistants. A review of personnel records indicated that the two facilities together could contribute about 795 person/years to the NIOSH study. The authors conclude that the two facilities should be included in the NIOSH study. Specific recommendations include installing double valves on the ethylene-oxide supply lines and relocating the local exhaust vent at the Union facility and reducing exposures of the process operators and assistants at the Bound Brook installation.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.